Luis Matamala
- Oncology top 10%
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 9
-
- Immunotherapy and Immune Responses 3
-
- Carcinogens and Genotoxicity Assessment 1
-
- Melanoma and MAPK Pathways 4
-
- Gastric Cancer Management and Outcomes 2
-
- Nutrition, Genetics, and Disease 1
- BRCA gene mutations in cancer 1
- Co-authors
- Hiroshi TokiwaReiko NakagawaKazumi HorikawaShigeji KitamoriF. Stephen HodiStéphane DalleDirk SchadendorfJean‐Jacques Grob
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- ChileUnited StatesAustralia
In The Last Decade
Luis Matamala
13 papers receiving 380 citations
Peers
Comparison fields: 5 of 56
- Oncology 251
- Immunology 135
- Cancer Research 87
- Health, Toxicology and Mutagenesis 53
- Chemical Health and Safety 1
Countries citing papers authored by Luis Matamala
This map shows the geographic impact of Luis Matamala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Matamala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Matamala more than expected).
Fields of papers citing papers by Luis Matamala
This network shows the impact of papers produced by Luis Matamala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Matamala. The network helps show where Luis Matamala may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luis Matamala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 24 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 68 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 33 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 118 | |
| 11 | 2018 | 0 | |
| 12 | 2017 | 29 | |
| 13 | 1990 | 3 | |
| 14 | 1983 | 74 |
About Luis Matamala
Luis Matamala is a scholar working on Oncology, Gastroenterology and Immunology, having authored 14 papers that have together received 388 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (3 papers), Gastric Cancer Management and Outcomes (2 papers), Nutrition, Genetics, and Disease (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (251 citations), Immunology (135 citations) and Cancer Research (87 citations). Luis Matamala has collaborated with scholars based in Chile, United States and Australia. Frequent co-authors include Hiroshi Tokiwa, Reiko Nakagawa, Kazumi Horikawa, Shigeji Kitamori, F. Stephen Hodi, Stéphane Dalle, Dirk Schadendorf, Jean‐Jacques Grob, Evan J. Lipson and Georgina V. Long. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.